cagri

Cagrisema 10mg

Semaglutide

Semaglutide

Price range: $80.00 through $140.00
BPC-157, TB-500 10mg

BPC-157, TB-500 10mg

$100.00

$150.00

Cagrisema is a potent new blend, a combination that integrates two peptides – cagrilintide and semaglutide.

 

Semaglutide is a GLP-1 receptor agonist; a version of human GLP-1 hormone, modified to resist the degradation by the enzyme dipeptidyl peptidase-4. 

Cagrilintdide, on the other hand, is an amylin analogue. Its role is to mimic the human hormone amylin and is structurally designed to be resistant to enzymatic degradation.

 

Together, these two peptides profoundly influence chemical structures and induce hormonal changes:

  • Leading to the receptor changes within the pancreas and the brain
  • Boosting insulin secretion 
  • Interacting with the receptors involved in appetite regulation
  • Mimicking the action of amylin
  • Decreasing glucagon secretion

 

All in all, this is a sophisticated, more importantly, incredibly potent combination of two peptides whose actions complement each other. Cagrisema combination influences some key hormonal processes and plays a role in metabolic regulation.

  •  Size Guide

    Size Guide

  •  Delivery & Return

    Delivery

    Store delivery FREE

    1-3 working days

    Home or collection point from £35.00 FREE

    On all your orders for home or collection point delivery

    Returns

    Return

    We will accept exchanges and returns of unworn and unwashed garments within 30 days of the date of purchase (14 days during the sales period).

    Returns in store FREE

    Your return will usually be processed within a week to a week and a half. We’ll send you a Return Notification email to notify you once the return has been completed. Please allow 1-3 business days for refunds to be received to the original form of payment once the return has been processed.

  •  Ask a Question
  ... people are viewing this right now
View Product Information

Nowadays, people have become obsessed with losing weight and considering that obesity has been associated with many health problems, it’s no wonder why individuals are seeking alternative solutions.

Among other available options, medications have gained a lot of popularity among patients and people looking to manage their weight, particularly CagriSema. While still under research, this peptide hasn’t been approved for human consumption, even though it has shown remarkable results in laboratory settings.

CagriSema Research

CagriSema, Obesity, and Weight Loss

This investigational drug has been designed to target metabolic disorders and to address some of the most pressing health issues, such as type 2 diabetes and obesity. CagriSema is classified as a novel treatment that combines two active ingredients, Semaglutide and Cagrilintide.

Semaglutide is widely recognized as a GLP-1 receptor agonist, Cagrilintide is an amylin analog, and when these two are combined, they offer a unique mechanism of action. Semaglutide is crucial for regulating glucose levels and suppressing appetite. It replicates the function of GLP-1, a hormone that boosts insulin secretion, slows gastric emptying and obstructs glucagon release.

Therefore, this peptide reduces food intake and improves glucose control. On the other hand, Cagrilintide mimics the actions of the natural hormone amylin, pancreatic beta cells released together with insulin. Amylin supports the actions of insulin by promoting satiety, slowing gastric emptying, and obstructing glucagon secretion.

When these two agents are combined, it addresses several actions, such as excess body weight and hyperglycemia, which are two crucial components of metabolic disorders.

CagriSema and Type 2 Diabetes

Based on animal research, scientists have been able to single out a couple of indications, including obesity and type 2 diabetes. These two conditions coexist and speed up each other, which leads to a vicious cycle that is challenging to break with monotherapy.

Type 2 diabetes causes insulin resistance and disrupts insulin secretion, while obesity further complicates the metabolic landscape, enhancing the risk of hypertension and cardiovascular disorders.

In clinical trials, scientists conducted research on mice and managed to conclude that CagriSema can potentially interrupt this cycle by offering dual benefits, substantial weight reduction, and better glycemic control. These trials have shown that CagriSema can significantly reduce HbA1c levels while promoting weight loss.

Summary

This peptide has shown promising results in laboratory settings. Its involvement in hormonal and metabolic processes could potentially make it a foundation for complex biological interactions. While scientists need to conduct a full scale of research and finalize their findings, its unique application helps us understand how synthetic peptides work and their influence on complex biological systems.

Researchers advise the responsible use of CagriSema only within scientific facilities and laboratories to ensure that findings remain accurate and within ethical boundaries.

References:

  • Frias JP, Deenadayalan S, Erichsen L, Knop FK, Lingvay I, Macura S, Mathieu C, Pedersen SD, Davies M. Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial. Lancet. 2023 Aug 26;402(10403):720-730. doi: 10.1016/S0140-6736(23)01163-7. Epub 2023 Jun 23. PMID: 37364590.
  • Apovian CM, McDonnell ME. CagriSema and the link between obesity and type 2 diabetes. Lancet. 2023 Aug 26;402(10403):671-673. doi: 10.1016/S0140-6736(23)01291-6. Epub 2023 Jun 23. PMID: 37364591.
  • Kokkorakis M, Chakhtoura M, Rhayem C, Al Rifai J, Ghezzawi M, Valenzuela-Vallejo L, Mantzoros CS. Emerging Pharmacotherapies for Obesity: A Systematic Review. Pharmacol Rev. 2024 Sep 20:PHARMREV-AR-2023-001045. doi: 10.1124/pharmrev.123.001045. Epub ahead of print. PMID: 39304347.

 

0.00
0 reviews
5
0
4
0
3
0
2
0
1
0
Thank you! Your review has been submitted
Be the first to review “Cagrisema 10mg”

Your email address will not be published. Required fields are marked *

This field is required.

This field is required.

This field is required.

Be the first to review “Cagrisema 10mg”

Reviews

There are no reviews yet.

Related Products

BPC-157 10mg
BPC-157 10mg $80.00

BPC‑157 (Body Protection Compound‑157) is a stable synthetic pentadecapeptide (15 amino acids) originally derived from a protective peptide found in gastric juice, widely studied for its cytoprotective and regenerative potential.
​
Preclinical research suggests it may support soft‑tissue repair (tendons/ligaments), modulate inflammation, and influence vascular signaling involved in healing.
​
Human evidence remains limited, so it is typically positioned as a research compound rather than an approved medicine.​

Add to cart
NAD+ 100mg
NAD+ 100mg
Variants
Price range: $45.00 through $120.00

*THESE STATEMENTS HAVE NOT BEEN EVALUATED BY THE FOOD AND DRUG ADMINISTRATION. THIS PRODUCT IS NOT INTENDED TO DIAGNOSE, TREAT, CURE OR PREVENT ANY DISEASE.

Nicotinamide adenine dinucleotide, or NAD+, is an oxidized form of NADH and one of the most crucial molecules in the body of the host as it facilitates cellular respiration. Its main biological function is to shuttle energy around – within the cell, to the extracellular space as well as between cells.

 

NAD+’s primary function is electron transport between different biochemical reactions within cells and, in some cases, even in the extracellular space. This is what makes these reactions possible and what reflects in the mitochondria – through new cell generation, improved cellular functioning and DNA repairs.

Select options
Cagrilintide
Cagrilintide
Variants
Price range: $130.00 through $230.00

Buy Cagrilintide Online

Cagrilintide is a long-acting amylin analogue, currently at the forefront of peptide research due to its rather interesting potential beneficial effect in individuals with diabetes. But what’s so special about amylin? Well, amylin is another peptide hormone, co-secreted with insulin, which inhibits food intake, delays gastric emptying, and, most importantly, reduces blood glucose levels.

 

Back to cagrilintide… it was originally developed to improve on the initial amylin analogue called pramlintide. The problem with pramlintide is its short half-life and undesired side effects.

 

Cagrilintide was (and still is being) developed to alter the half-life, potency and stability of pramlintide, and other amylin analogues.Since, it’s still a relatively new peptide, it still needs to undergo further research so we can make sure its as effective and safe.

Select options
AOD9604 5mg
AOD9604 5mg $50.00

AOD9604 is a derivative of human growth hormone (hGH) and a modified version of the hGH fragment 176-191 peptide, incorporating a di-sulfide bridge. What’s exciting about this peptide is that it does not affect IGF-1 or insulin levels and is, therefore, not a risk in promoting glucose intolerance. 

Add to cart
CJC-1295, Ipamorelin 10mg
CJC-1295, Ipamorelin 10mg $85.00

CJC-1295 with DAC is a synthetic peptide, analog of the growth hormone-releasing hormone. Though CJC-1295 without DAC has the same effect and stimulates the production and secretion of growth hormone, the addition of Drug Affinity Complex (DAC) is what increases its half-life allowing it to act longer and more potently. 

Research in animals also suggests that CJC-1295 with DAC stimulates insulin-like growth factor 1 (IGF-1) and plays a part in a number of physiological processes.

References: 

  1. https://pubmed.ncbi.nlm.nih.gov/16352683/
  2. https://pmc.ncbi.nlm.nih.gov/articles/PMC2787983/
  3. https://academic.oup.com/jcem/article-abstract/91/3/799/2843281?redirectedFrom=fulltext
  4. https://www.researchgate.net/publication/7416716_Prolonged_Stimulation_of_Growth_Hormone_GH_and_Insulin-Like_Growth_Factor_I_Secretion_by_CJC-1295_a_Long-Acting_Analog_of_GH-Releasing_Hormone_in_Healthy_Adults
Add to cart
BBG70 GLOW - BPC -157 10mg + GHKCU 50mg + TB500 10mg
BBG70 GLOW – BPC -157 10mg + GHKCU 50mg + TB500 10mg $180.00

BPC-157 5mg, TB-500 (Thymosin Beta-4) 5 mg , GHK-Cu 20 mg
(Total Glow Blend)

The BPC-157, TB-500 (Thymosin Beta-4), and GHK-Cu mix is a mix of three different peptides, measured at 5 mg of BPC-157, 5 mg of TB-500, and 20 mg of GHK-Cu, for a total of 30 mg.

Researchers have been interested in BPC-157, a peptide initially isolated from gastric proteins, because of its ability to promote the growth of blood vessels and healing of injured tissue through a range of cellular mechanisms.

TB-500, a naturally occurring fragment of a larger protein, is typically studied for its ability to migrate cells into injured areas. It encourages the formation of new blood vessels, and reduces inflammation, especially in muscle and connective tissue.

The third ingredient, GHK-Cu, is a low molecular weight copper-binding peptide that has been linked in studies to wound healing, collagen synthesis, and even hair growth stimulation.

 

Together, these three compounds appear to have an effect on the same biological processes, but with a broader effect than any of them would have in isolation.

For example, TB-500 and BPC-157 both cause the growth of new vessels, while GHK-Cu adds another layer of support by activating the growth of the cells that line blood vessels.

On the structural repair side of tissues, TB-500 enables cell migration by promoting actin activity, while GHK-Cu and BPC-157 both influence fibroblasts and collagen to offer support for stronger connective tissue.

A second point of overlap is in reducing inflammation and oxidative stress, and it may be here that researchers are hopeful for these peptides in longer-term recovery studies.

As a result of these synergistic and shared activities, the blend is being investigated for use in everything ranging from musculoskeletal trauma to wound healing and post-surgical recovery.

Add to cart
HCG 5000IU
HCG 5000IU $70.00

Human Chorionic Gonadotropin (HCG) is a peptide hormone primarily produced by the placenta during pregnancy. It plays a vital role in supporting fetal development by stimulating the production of essential hormones such as progesterone, helping maintain a healthy pregnancy.

In research settings, HCG is studied for its potential effects on hormonal regulation, metabolic processes, and physiological responses.

Storage & Handling:
To maintain the stability and integrity of this product, store it in a cool, dry place, away from direct sunlight. Handle with care and follow standard laboratory procedures to ensure accurate and reliable results.

Add to cart
KLOW - KPV 10mg+BPC 157 10mg+GHK-CU50mg+TB500 10mg
KLOW – KPV 10mg+BPC 157 10mg+GHK-CU50mg+TB500 10mg $180.00

The BPC157, TB500, KPV, and GHK-Cu Quad Blend is a premium peptide formulation developed for advanced research into healing, regeneration, and anti-aging. This unique combination brings together four peptides that complement each other through distinct biological pathways. BPC157 has been widely studied for its ability to promote tissue repair, improve circulation, and support the stomach and intestinal lining. TB500, the complete Thymosin Beta-4 peptide, plays a vital role in cellular movement and recovery, helping researchers explore mechanisms of wound and muscle regeneration. KPV, a naturally occurring tripeptide, is valued for its anti-inflammatory and antimicrobial activity, helping to regulate immune response and reduce tissue stress. GHK-Cu, a copper-binding peptide, is known to stimulate collagen synthesis and rejuvenate skin and hair cells, promoting overall cellular renewal.

When combined, these four compounds may act synergistically to support studies on recovery and long-term cellular health. The blend is produced in a GMP-certified facility, tested for ≥99% purity, and provided in lyophilized powder form to ensure stability and reliability for laboratory use. Designed strictly for research purposes, this blend offers scientists a powerful tool to study natural healing and regenerative processes.

Add to cart
Tirzepatide
Tirzepatide
Variants
Price range: $80.00 through $260.00

Tirzepatide is a synthetic peptide investigated and used clinically for its incretin-based metabolic activity, designed to activate key pathways involved in glycemic control and appetite regulation.

As a dual incretin receptor agonist (GIP/GLP‑1), it is associated with clinically meaningful effects on body weight and metabolic markers in studied populations.

This injectable peptide is typically positioned for advanced metabolic research where receptor-driven appetite and glucose signaling are the primary focus.

Select options
BPC-157, TB-500 10mg
BPC-157, TB-500 10mg $100.00

Body protection compound 157, or BPC for short, is a 15 amino acid segment of a specific body protection compound fragment. 

 

Research showed that BPC-157 presents itself with potent cytoprotective properties, protecting cells from gastric mucosal damage. Though this exact mechanism is not yet fully known, researchers believe it has to do with the brain-gut axis which enables the communication between central nervous and endocrine systems.

 

TB-500 is a synthetic variation of the naturally occurring Thymosin-beta-4, and is built up of 43 amino acids. This peptide plays an important role in polymerization regulation, cell proliferation, migration and differentiation. 

 

Putting these two peptides in a blend together gives a powerful cell protection effect, as well as improved recovery and differentiation on a cellular level.

References: 

  1. https://pmc.ncbi.nlm.nih.gov/articles/PMC6271067/  
Add to cart
Retatrutide
Retatrutide
Variants
Price range: $90.00 through $160.00

Retatrutide is an investigational multi-receptor agonist peptide designed to target multiple metabolic hormone pathways involved in appetite, energy expenditure, and glucose regulation.
It is most often described as a next-generation approach to weight-management research due to its combined incretin and glucagon-pathway activity.
This injectable peptide is primarily referenced in the context of clinical development and advanced metabolic research.

Select options
Tesamorelin
Tesamorelin $70.00

*THESE STATEMENTS HAVE NOT BEEN EVALUATED BY THE FOOD AND DRUG ADMINISTRATION. THIS PRODUCT IS NOT INTENDED TO DIAGNOSE, TREAT, CURE OR PREVENT ANY DISEASE.

Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analog. It was based on the 44 amino acids sequence of GHRH and contains a trans-3 hexenoic group to protect it from enzymatic degradation. These modifications allow it to be more stable and have a longer half-life.

 

Just like Sermorelin, Ipamorelin or GHRP-2, Tesamorelin is considered a growth hormone secretagogue (GHS) which stimulates the secretion of GH and increases the level of insulin-like growth factor (IGF-1). The importance of IGF-1 is it tends to be lower in patients with obesity, diabetes and especially in those with lipodystrophy.

References: 

  1. Sinha DK, Balasubramanian A, Tatem AJ, Rivera-Mirabal J, Yu J, Kovac J, Pastuszak AW, Lipshultz LI. Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males. Transl Androl Urol. 2020 Mar;9(Suppl 2):S149-S159. doi: 10.21037/tau.2019.11.30. PMID: 32257855; PMCID: PMC7108996.
Add to cart
Popular Searches: BPC-157 AOD9604...
My Cart
Recently Viewed
Categories
Cagrisema 10mg

Cagrisema 10mg

$150.00

Request a Call Back

    Cagrisema 10mg

    Cagrisema 10mg

    $150.00

    Ask a Question